Duck-Woo Kim
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Duck-Woo Kim has a total of 279 co-authors. Here are the top co-authors by number of shared publications:
- Heung-Kwon Oh
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
46 shared publications - Sung-Bum Kang
Correspondence to: Sung-Bum Kang, MD, PhD Department of Surgery, Seoul National University Bundang Hospital, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 13620, Korea
35 shared publications Sung-Bum Kang
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Republic of Korea
20 shared publications- Hong-Min Ahn
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
18 shared publications - Mi Jeong Choi
Department of Surgery, Seoul National University Bundang Hospital, Seongnam, Korea
11 shared publications - Hye Seung Lee
Department of Pathology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea
9 shared publications
Latest Publications
- Open Access
- 1 January 2027
- Published by XMLink in Journal of Korean Medical Science
- Vol. 42
Long-Term Abstinence Following Preoperative Smoking Cessation Interventions in Elective Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Shin HK, et al. J Korean Med Sci. 2027 Feb;42:e33. https://doi.org/10.3346/jkms.2027.42.e33
- 1 January 2027
- Published by XMLink in Journal of Korean Medical Science
- Vol. 42
Open AccessLong-Term Abstinence Following Preoperative Smoking Cessation Interventions in Elective Surgery: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Shin HK, et al. J Korean Med Sci. 2027 Feb;42:e33. https://doi.org/10.3346/jkms.2027.42.e33
- Open Access
- 31 October 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (5) , 545-552
Transverse colon cancer as an independent predictor of locoregional recurrence in patients with stage III colon cancer: a retrospective cohort study
Purpose: This study aimed to evaluate the significance of transverse colon cancer as a predictor of locoregional recurrence in patients with stage III colon cancer.Methods: This single-center retrospective cohort study included 1,302 patients who underwent curative-intent laparoscopic colectomy for stage III colon cancer between 2003 and 2021. The primary outcome was locoregional recurrence, defined as tumor recurrence near the anastomotic site, regional lymph nodes, or peritoneal recurrence around the primary tumor. Multivariate analyses were conducted to identify the factors associated with locoregional recurrence.Results: Transverse colon cancer was identified in 151 patients (11.6%). Baseline characteristics were similar, but transverse colon cancer exhibited a higher locoregional recurrence rate than nontransverse colon cancer (7.9% vs. 2.0%, P<0.001). In transverse colon cancer, locoregional recurrence did not differ according to high ligation of the mid-colic vessel (without high ligation, 10.6% vs. high ligation, 6.7%; P=0.517), and 10 of 12 recurrences (83.3%) occurred predominantly in the regional lymph nodes. In multivariate analysis, transverse colon (hazard ratio [HR], 4.513; 95% confidence interval [CI], 2.226–9.154; P<0.001) and N2 category (HR, 2.044; 95% CI, 1.034–4.042; P=0.040) emerged as independent predictors of locoregional recurrence. Disease-free survival (73.8% vs. 79.2%, P=0.217) and overall survival (84.7% vs. 86.3%, P=0.735) in 5 years were not different between transverse and nontransverse colon cancer.Conclusion: Transverse colon cancer may serve as an independent predictor of locoregional recurrence in stage III colon cancer. The predominance of regional lymph node recurrence emphasizes the importance of careful regional lymph node assessment in transverse colon cancer.
- 31 October 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (5) , 545-552
Open AccessTransverse colon cancer as an independent predictor of locoregional recurrence in patients with stage III colon cancer: a retrospective cohort study
Purpose: This study aimed to evaluate the significance of transverse colon cancer as a predictor of locoregional recurrence in patients with stage III colon cancer.Methods: This single-center retrospective cohort study included 1,302 patients who underwent curative-intent laparoscopic colectomy for stage III colon cancer between 2003 and 2021. The primary outcome was locoregional recurrence, defined as tumor recurrence near the anastomotic site, regional lymph nodes, or peritoneal recurrence around the primary tumor. Multivariate analyses were conducted to identify the factors associated with locoregional recurrence.Results: Transverse colon cancer was identified in 151 patients (11.6%). Baseline characteristics were similar, but transverse colon cancer exhibited a higher locoregional recurrence rate than nontransverse colon cancer (7.9% vs. 2.0%, P<0.001). In transverse colon cancer, locoregional recurrence did not differ according to high ligation of the mid-colic vessel (without high ligation, 10.6% vs. high ligation, 6.7%; P=0.517), and 10 of 12 recurrences (83.3%) occurred predominantly in the regional lymph nodes. In multivariate analysis, transverse colon (hazard ratio [HR], 4.513; 95% confidence interval [CI], 2.226–9.154; P<0.001) and N2 category (HR, 2.044; 95% CI, 1.034–4.042; P=0.040) emerged as independent predictors of locoregional recurrence. Disease-free survival (73.8% vs. 79.2%, P=0.217) and overall survival (84.7% vs. 86.3%, P=0.735) in 5 years were not different between transverse and nontransverse colon cancer.Conclusion: Transverse colon cancer may serve as an independent predictor of locoregional recurrence in stage III colon cancer. The predominance of regional lymph node recurrence emphasizes the importance of careful regional lymph node assessment in transverse colon cancer.
- Open Access
- 31 August 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (4) , 446-453
Extraperitoneal tunneling reduces intraperitoneal drain displacement in rectal cancer surgery: a single-center before-and-after comparative study
Purpose: Anastomotic leakage (AL) is a serious complication of rectal cancer surgery, and a properly positioned pelvic drain may aid early detection and conservative management; however, intraperitoneal drains frequently migrate. We evaluated whether extraperitoneal tunneling (EPT) of the pelvic drain reduces drain displacement compared with conventional intraperitoneal placement.Methods: This single-center before-and-after comparative study enrolled adults with rectal cancer located within 15 cm of the anal verge who underwent elective radical resection between August 2021 and July 2024. Patients operated between August 2021 and December 2022 received conventional intraperitoneal drains (non-EPT group) and those operated between January 2023 and July 2024 received EPT drains (EPT group). The primary outcome was drain displacement (>3 cm from the anastomotic staple line) on postoperative day 2 plain radiograph. Secondary outcomes were AL, EPT-related complications, and the need for additional intervention. Multivariate logistic regression, propensity score matching (PSM), and inverse probability of treatment weighting (IPTW) were performed.Results: Of 228 patients, 111 received EPT and 117 received conventional drains. Drain displacement occurred in 5 of 111 EPT patients (4.5%) versus 55 of 117 non-EPT patients (47.0%; P<0.001). After multivariate adjustment, EPT was an independent protective factor (adjusted odds ratio [OR], 0.05; 95% confidence interval [CI], 0.02–0.13; P<0.001). The protective association was robust across PSM (matched OR, 0.07; 95% CI, 0.02–0.18) and IPTW (OR, 0.05–0.06; both P<0.001). AL occurred in 6 patients (2.6%) without a significant between-group difference (EPT, 1.8% vs. non-EPT, 3.4%; Fisher exact, P=0.681). Operative time, overall complications, and EPT-related complications did not differ between groups.Conclusion: In this single-center before-and-after series, EPT was associated with a substantially lower rate of postoperative day 2 drain displacement after rectal cancer surgery.
- 31 August 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (4) , 446-453
Open AccessExtraperitoneal tunneling reduces intraperitoneal drain displacement in rectal cancer surgery: a single-center before-and-after comparative study
Purpose: Anastomotic leakage (AL) is a serious complication of rectal cancer surgery, and a properly positioned pelvic drain may aid early detection and conservative management; however, intraperitoneal drains frequently migrate. We evaluated whether extraperitoneal tunneling (EPT) of the pelvic drain reduces drain displacement compared with conventional intraperitoneal placement.Methods: This single-center before-and-after comparative study enrolled adults with rectal cancer located within 15 cm of the anal verge who underwent elective radical resection between August 2021 and July 2024. Patients operated between August 2021 and December 2022 received conventional intraperitoneal drains (non-EPT group) and those operated between January 2023 and July 2024 received EPT drains (EPT group). The primary outcome was drain displacement (>3 cm from the anastomotic staple line) on postoperative day 2 plain radiograph. Secondary outcomes were AL, EPT-related complications, and the need for additional intervention. Multivariate logistic regression, propensity score matching (PSM), and inverse probability of treatment weighting (IPTW) were performed.Results: Of 228 patients, 111 received EPT and 117 received conventional drains. Drain displacement occurred in 5 of 111 EPT patients (4.5%) versus 55 of 117 non-EPT patients (47.0%; P<0.001). After multivariate adjustment, EPT was an independent protective factor (adjusted odds ratio [OR], 0.05; 95% confidence interval [CI], 0.02–0.13; P<0.001). The protective association was robust across PSM (matched OR, 0.07; 95% CI, 0.02–0.18) and IPTW (OR, 0.05–0.06; both P<0.001). AL occurred in 6 patients (2.6%) without a significant between-group difference (EPT, 1.8% vs. non-EPT, 3.4%; Fisher exact, P=0.681). Operative time, overall complications, and EPT-related complications did not differ between groups.Conclusion: In this single-center before-and-after series, EPT was associated with a substantially lower rate of postoperative day 2 drain displacement after rectal cancer surgery.
- 22 May 2026
- Published by Wolters Kluwer Health in Annals of Surgery
Management of Responsive Lateral Pelvic Nodes After Neoadjuvant Therapy in Rectal Cancer (RESPONDER)
Objective: To determine whether lateral pelvic lymph node dissection improves oncological outcomes in patients with rectal cancer with radiologically responsive lateral pelvic nodes (LPNs) following neoadjuvant chemoradiotherapy (nCRT). Summary Background Data: The optimal management of radiologically responsive LPNs after nCRT remains unclear. Methods: This retrospective cohort study included patients with mid-to-low rectal adenocarcinoma who underwent radical resection between 2012 and 2022 at eight tertiary centers. Eligible patients had baseline magnetic resonance imaging evidence of lateral pelvic node enlargement (short-axis ≥5 mm) that decreased to P P =0.011). The 5-year local recurrence, disease-free survival, and overall survival rates were 3.1% vs. 5.3% (hazard ratio [HR], 0.738; 95% confidence interval [CI], 0.207–2.634; P =0.640), 77.1% vs. 71.4% (HR, 0.80; 95% CI, 0.50–1.29), and 87.0% vs. 86.9% (HR, 0.79; 95% CI, 0.22–2.81) with and without lymph node dissection, respectively. Conclusions: Among patients with radiologically responsive LPNs after nCRT, omission of lateral pelvic lymph node dissection did not compromise oncological outcomes. These data support a response-based surgical strategy to reduce operative morbidity without affecting recurrence or survival rates.
- 22 May 2026
- Published by Wolters Kluwer Health in Annals of Surgery
Management of Responsive Lateral Pelvic Nodes After Neoadjuvant Therapy in Rectal Cancer (RESPONDER)
Objective: To determine whether lateral pelvic lymph node dissection improves oncological outcomes in patients with rectal cancer with radiologically responsive lateral pelvic nodes (LPNs) following neoadjuvant chemoradiotherapy (nCRT). Summary Background Data: The optimal management of radiologically responsive LPNs after nCRT remains unclear. Methods: This retrospective cohort study included patients with mid-to-low rectal adenocarcinoma who underwent radical resection between 2012 and 2022 at eight tertiary centers. Eligible patients had baseline magnetic resonance imaging evidence of lateral pelvic node enlargement (short-axis ≥5 mm) that decreased to P P =0.011). The 5-year local recurrence, disease-free survival, and overall survival rates were 3.1% vs. 5.3% (hazard ratio [HR], 0.738; 95% confidence interval [CI], 0.207–2.634; P =0.640), 77.1% vs. 71.4% (HR, 0.80; 95% CI, 0.50–1.29), and 87.0% vs. 86.9% (HR, 0.79; 95% CI, 0.22–2.81) with and without lymph node dissection, respectively. Conclusions: Among patients with radiologically responsive LPNs after nCRT, omission of lateral pelvic lymph node dissection did not compromise oncological outcomes. These data support a response-based surgical strategy to reduce operative morbidity without affecting recurrence or survival rates.
- 30 April 2026
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 30 (8) , 102447
The Impact of Lymph Node Harvest on Recurrence in Rectal Cancer Following Neoadjuvant Chemoradiotherapy
- 30 April 2026
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 30 (8) , 102447
The Impact of Lymph Node Harvest on Recurrence in Rectal Cancer Following Neoadjuvant Chemoradiotherapy
- Open Access
- 30 April 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (2) , 258-260
Laparoscopic left hemicolectomy with articulated forceps for colocutaneous fistulizing Crohn disease
- 30 April 2026
- Published by Korean Society of Coloproctology in Annals of Coloproctology
- Vol. 42 (2) , 258-260
Open AccessLaparoscopic left hemicolectomy with articulated forceps for colocutaneous fistulizing Crohn disease
- Open Access
- 15 April 2026
- Published by Korean Cancer Association in Cancer Research and Treatment
Is Complete Mesocolic Excision with Central Vascular Ligation Necessary for Suspected Early-stage Right-sided Colon Cancer?
Is Complete Mesocolic Excision with Central Vascular Ligation Necessary for Suspected Early-stage Right-sided Colon Cancer?
- 15 April 2026
- Published by Korean Cancer Association in Cancer Research and Treatment
Open AccessIs Complete Mesocolic Excision with Central Vascular Ligation Necessary for Suspected Early-stage Right-sided Colon Cancer?
Is Complete Mesocolic Excision with Central Vascular Ligation Necessary for Suspected Early-stage Right-sided Colon Cancer?
- Open Access
- 7 April 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26
Prognostic utility of sarcopenia and frailty on postoperative complication and mortality in older intermediate risk cancer surgery
Conditions such as sarcopenia and frailty, which become more prevalent with age, significantly influence the outcomes of older patients with cancer undergo
- 7 April 2026
- Published by Springer Nature in BMC Geriatrics
- Vol. 26
Open AccessPrognostic utility of sarcopenia and frailty on postoperative complication and mortality in older intermediate risk cancer surgery
Conditions such as sarcopenia and frailty, which become more prevalent with age, significantly influence the outcomes of older patients with cancer undergo
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (4) , 237-245
Improving prediction of ypT0–1N0 response in rectal cancer: the added value of gross tumor type to magnetic resonance tumor regression grade after chemoradiotherapy in a retrospective cohort study
Kang KM, et al. Ann Surg Treat Res. 2026 Apr;110(4):237-245. https://doi.org/10.4174/astr.2026.110.4.237
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (4) , 237-245
Open AccessImproving prediction of ypT0–1N0 response in rectal cancer: the added value of gross tumor type to magnetic resonance tumor regression grade after chemoradiotherapy in a retrospective cohort study
Kang KM, et al. Ann Surg Treat Res. 2026 Apr;110(4):237-245. https://doi.org/10.4174/astr.2026.110.4.237
- Open Access
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (1) , 1-2
Current issue on special topic: robotic single-port system in general surgery
Kim DW. Ann Surg Treat Res. 2026 Jan;110(1):1-2. https://doi.org/10.4174/astr.2026.110.1.1
- 1 January 2026
- Published by XMLink in Annals of Surgical Treatment and Research
- Vol. 110 (1) , 1-2
Open AccessCurrent issue on special topic: robotic single-port system in general surgery
Kim DW. Ann Surg Treat Res. 2026 Jan;110(1):1-2. https://doi.org/10.4174/astr.2026.110.1.1